SARS-CoV-2 vaccination and risk of infectious diseases in hospitalized older patients
- PMID: 38182805
- DOI: 10.1007/s41999-023-00902-x
SARS-CoV-2 vaccination and risk of infectious diseases in hospitalized older patients
Abstract
Purpose: Vaccinations, for example flu vaccine, may be a cause of cross-reactive immunostimulation that prevents a larger spectrum of infections. However, whether SARS-CoV-2 vaccinations may also determine this effect is unclear. This study aims, first, to assess the incidence of infections at hospital admission and during the hospitalization in older inpatients vaccinated and unvaccinated against SARS-CoV-2; second, to compare length of hospital stay and in-hospital mortality between vaccinated and unvaccinated individuals.
Methods: This retrospective study included 754 older inpatients admitted to the Geriatrics and Orthogeriatrics Units of the University Hospital of Ferrara (Italy) between March 2021 and November 2021. Sociodemographic and health-related data, and the diagnosis of infections at hospital admission and during hospitalization were collected from medical records.
Results: The sample's mean age was 87.2 years, 59.2% were females, and 75.5% were vaccinated against SARS-CoV-2. Vaccinated individuals had 36% lower odds of intra-hospital infections (OR = 0.64, 95%CI 0.44-0.94) and 39% lower in-hospital death (HR = 0.61, 95%CI 0.39-0.95), also after adjusting for potential confounders, while no significant results emerged about infections at hospital admission. Considering the hospitalization's endpoints, SARS-CoV-2 vaccination was associated with a lower probability of being transferred to long-term care or other hospital departments than returning home (OR = 0.63, 95%CI 0.40-0.99).
Conclusions: In older inpatients, SARS-CoV-2 vaccination seems to be associated with a lower likelihood of intra-hospital infectious diseases not caused by SARS-CoV-2 and all-cause in-hospital mortality. The vaccination coverage in the older population could limit not only the onset and severity of COVID-19 but also the occurrence of other infectious diseases.
Keywords: Aged; Hospitalization; Intra-hospital infections; Mortality; SARS-CoV-2 vaccination.
© 2024. The Author(s), under exclusive licence to European Geriatric Medicine Society.
Similar articles
-
Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.JAMA Netw Open. 2022 Oct 3;5(10):e2238871. doi: 10.1001/jamanetworkopen.2022.38871. JAMA Netw Open. 2022. PMID: 36301541 Free PMC article.
-
Impact of vaccination against SARS-CoV-2 on mortality risk, ICU admission rate, and hospitalization length in hospitalized COVID-19 patients: a cross-sectional study.BMC Infect Dis. 2025 Jan 31;25(1):144. doi: 10.1186/s12879-025-10530-4. BMC Infect Dis. 2025. PMID: 39885405 Free PMC article.
-
Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older.JAMA Netw Open. 2022 Sep 1;5(9):e2233730. doi: 10.1001/jamanetworkopen.2022.33730. JAMA Netw Open. 2022. PMID: 36169955 Free PMC article.
-
Differences in characteristics and outcomes of older patients hospitalized for COVID-19 after introduction of vaccination.Eur Geriatr Med. 2024 Aug;15(4):941-949. doi: 10.1007/s41999-024-01002-0. Epub 2024 Jun 11. Eur Geriatr Med. 2024. PMID: 38861241 Free PMC article.
-
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy.J Infect Public Health. 2024 Mar;17(3):467-473. doi: 10.1016/j.jiph.2023.12.026. Epub 2024 Jan 17. J Infect Public Health. 2024. PMID: 38262085
Cited by
-
Assessing the impact of vaccines on COVID-19 efficacy in survival rates: a survival analysis approach for clinical decision support.Front Public Health. 2024 Nov 18;12:1437388. doi: 10.3389/fpubh.2024.1437388. eCollection 2024. Front Public Health. 2024. PMID: 39624415 Free PMC article.
-
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia.J Transl Med. 2024 Aug 12;22(1):755. doi: 10.1186/s12967-024-05556-2. J Transl Med. 2024. PMID: 39135151 Free PMC article.
References
-
- Goto T, Yoshida K, Tsugawa Y, Camargo CA, Hasegawa K (2016) Infectious disease-related emergency department visits of elderly adults in the United States, 2011–2012. J Am Geriatr Soc 64:31–36. https://doi.org/10.1111/jgs.13836 - DOI - PubMed
-
- Levant S, Chari K, DeFrances CJ (2015) Hospitalizations for patients aged 85 and over in the United States, 2000–2010. NCHS Data Brief 1–8
-
- Curns AT, Steiner CA, Sejvar JJ, Schonberger LB (2008) Hospital charges attributable to a primary diagnosis of infectious diseases in older adults in the United States, 1998 to 2004. J Am Geriatr Soc 56:969–975. https://doi.org/10.1111/j.1532-5415.2008.01712.x - DOI - PubMed
-
- Liang SY (2016) Sepsis and other infectious disease emergencies in the elderly. Emerg Med Clin North Am 34:501–522. https://doi.org/10.1016/j.emc.2016.04.005 - DOI - PubMed - PMC
-
- Alves VP, Casemiro FG, Araujo BG de, Lima MA de S, Oliveira RS de, Fernandes FT de S, et al. (2021) Factors associated with mortality among elderly people in the COVID-19 pandemic (SARS-CoV-2): a systematic review and meta-analysis. Int J Environ Res Public Health 18:8008. https://doi.org/10.3390/ijerph18158008
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous